Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Middle East and Africa Anti-Fungal Agents Market Research Report Information, by Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis and Others), Drug Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines and Others) and Route of Administration (Oral, Local and Others) - Forecast to 2032


ID: MRFR/Pharma/1942-HCR | 84 Pages | Author: Rahul Gotadki| May 2024

Antifungal Agents Market Overview


The antifungal agents market will reach USD 6.88 billion and a CAGR of 5.5% in the forecast period 2023-2032.


The antifungal medication, called antimycotic medication, is a pharmaceutical fungicide for the treatment and prevention of mycoses like ringworm, candidiasis, cryptococcal meningitis, and others. There are antifungal drugs available to combat fungal infections. Antifungal drugs are diverse. They are given orally, with topical treatment, or via IV.


Antifungal agents are used for fungal infection treatment. According to the global action fund for fungal infection, over 300 billion suffer from a serious fungal infection every year.


The increased growth of the global antifungal market is due to the rise in cases of fungal and nosocomial infections. Additionally, the surge in initiatives by public and private organizations for awareness about fungal infections will expand the antifungal drugs market. Moreover, the growth of fungal infections such as aspergillosis and candidiasis is the key factor that propels the growth of the antifungal market.


The market drivers include rising concern of fungal infections, awareness, the rise of immunity deficient populations like geriatrics, exposure to infectious agents, and environmental factors such as pollution, particulates, and agriculture residues. The growth of fungal infection due to broad-spectrum antibiotics is another cause behind the growth of the antifungal agents market.


Middle East and Africa Anti-fungal Agents Market, by Product Type, 2015 (%):


 Anti-Fungal Agents Market Image


Study Objectives Middle East and Africa Anti-Fungal Agents Market:



  • To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa anti-fungal agents market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments for Middle East and Africa anti-fungal agents market

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by product type, by construction material, by end users and other sub segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


Intended Audience



  • Anti-fungal agents Manufacturers

  • Anti-fungal agents Suppliers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories

  • Contract Manufacturing Organizations


Key Players for Middle East and Africa Anti-fungal agents Market: Some of the key players in this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others.


Segments:


Middle East and Africa anti-fungal agents market has been segmented on the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. On the basis of route of administration; market is segmented into oral, local and others.Recent Development


In May 2022


SCYNEXIS, Inc., a global biotechnology company with pioneering innovative medicines to overcome and prevent drug-resistant infections, to present data from its ongoing FURI study of ibrexafungerp during the American College of Obstetricians and Gynecologists meeting being held in San Diego on May 6-8, 2022.


In May 2022


FDA Approves Vivjoa or Chronic Yeast Infections. It is the first FDA-approved trusted Source antifungal medication to treat yeast infection.


The FDA has approved the drug based on phase three clinical trials with 875 patients. Participants in one group received Vivjoa for an initial infection and then for 50 weeks as a maintenance medication. The second group received fluconazole, a traditional treatment for yeast infections, and a placebo for 50 weeks.


Regional Analysis of Middle East and Africa Anti-fungal agents Market:


UAE is the largest market for anti-fungal agents in entire Middle East and Africa anti-fungal Market closely followed by Egypt. The rest of Africa market is however the fastest growing with a huge unmet medical needs and peculiar climatic conditions that support growth of fungal infections.


The report for Middle East and Africa Anti-fungal agents Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Report Attribute/Metric Details
  Market Size   6.88 Billion
  CAGR   5.5%
  Base Year   2022
  Forecast Period   2023-2032
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   by Product Type, by Therapeutic Indication, Drug Class, Route of Administration
  Geographies Covered    North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others.
  Key Market Opportunities   new product developments, and research and developments globally.
  Key Market Drivers   rising concern of fungal infections, awareness


Frequently Asked Questions (FAQ) :

The MEA anti-fungal agents market is projected grow at approximately 5.5% CAGR during the assessment period (2023-2032).

The valuation of the MEA anti-fungal agents market is estimated to increase to USD 6.88 billion by the end of 2032.

Pfizer, Inc., Novartis AG, Sanofi-Aventis, Enzon Pharmaceuticals, Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc, Astellas Pharma, Inc., Abbott, and Sigma-Aldrich, are some of the major players operating in the MEA anti-fungal agents market.

The UAE holds the largest share in the MEA anti-fungal agents market, followed by Egypt and the rest of Africa, respectively.

Growing awareness among populaces, rising prevalence of fungal infections, and off label use of broad spectrum antibiotics are the major tailwinds pushing the growth of the MEA anti-fungal agents market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.